Richard Feng

Richard Feng is a Research Associate II in Downstream Process Development at Asklepios BioPharmaceutical, Inc. since March 2024. Prior to this role, Richard served as a Research Specialist at the University of North Carolina at Chapel Hill for nearly nine years, collaborating with both academic and industry clients on protein expression and purification while training lab personnel in various techniques. Richard possesses a strong background in molecular biology, having worked with mammalian cell lines and performed a range of experimental techniques throughout multiple roles, including as a Biologist I/QO Lab Analyst at Merck and a Laboratory Technician at Purdue University. Richard holds a Master of Science in Business Analytics from the University of North Carolina Wilmington and a Bachelor of Science in Cell, Molecular, and Developmental Biology from Purdue University.